Cash Flow

v3.25.3
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 9 Months Ended
Sep. 27, 2025
Sep. 28, 2024
Operating activities    
Net loss $ (38,879) $ (25,183)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:    
Depreciation and amortization expense 15,702 13,436
Amortization of intangible assets 40 33
Noncash interest expense 24 0
Share-based compensation expense 7,434 8,967
Stock awards issued for non-employee director service 40 31
Stock awards related to officers and directors stock purchase plan from payroll deferral 0 7
Loss (gain) from disposition of assets 4 (70)
Amortization of deferred financing costs 84 49
Loss on early lease termination 393 0
Changes in operating assets and liabilities:    
Accounts receivable (1,251) (1,063)
Inventory (3,930) 31,666
Other current assets (113) (355)
Other non-current assets (486) 261
Accounts payable and accrued expenses (5,151) (19,352)
Other current liabilities (509) (465)
Right-of-use obligation - operating leases - current (150) 1,259
Right-of-use obligation - operating leases - long-term 8 (772)
Other non-current liabilities 263 93
Net cash (used in) provided by operating activities (26,477) 8,542
Investing activities    
Additions to property and equipment (6,281) (18,146)
Payments for intangible assets 0 (76)
Proceeds from sale of property and equipment 0 92
Net cash used in investing activities (6,281) (18,130)
Financing activities    
Borrowings from revolving loan payable 20,565 168
Payments made on revolving loan payable (20,565) (168)
Proceeds from convertible notes payable 25,000 0
Payments on finance leases (2,615) (3,243)
Net proceeds from issuance of common stock for ESPP 154 359
Proceeds from Issuance of Common Stock 10,733 0
Payment of issuance costs - common stock (383) 0
Statutory tax withholding payment for share-based compensation (517) (461)
Net cash provided by (used in) financing activities 32,372 (3,345)
Effect of exchange rate changes on cash 0 87
Net change in cash and cash equivalents (386) (12,846)
Cash and cash equivalents, beginning of period 36,397 50,951
Cash and cash equivalents, end of period 36,011 38,105
Supplemental disclosure of non-cash investing and financing activities:    
Right-of-use operating asset acquired 0 12,857
Accrued asset purchases 396 907
Share-based compensation expense capitalized in property and equipment 685 561
Accrued issuance costs - purchase agreement 550 0
Supplemental disclosure of cash flow information:    
Cash paid during the period for income taxes 152 48
Cash paid during the period for interest 1,094 896
Cash received during the period for interest $ 631 $ 1,136

Source

10-Q Filing
PDF
XBRL
ZIP